ALECENSA vs FYARRO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. ALECENSA and FYARRO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALECENSA	FYARRO
Rating	New	New
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	ALECTINIB HYDROCHLORIDE	SIROLIMUS
Manufacturer	Hoffmann La Roche	Aadi
Dosage forms	Capsule	Injectable
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

alecensa fyarro

Rating

New

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

ALECTINIB HYDROCHLORIDE

SIROLIMUS

Manufacturer

Hoffmann La Roche

Aadi

Dosage forms

Capsule

Injectable

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Alecensa and Fyarro?

Alecensa contains Alectinib Hydrochloride, while Fyarro contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.